๐ฐ Chief Development News
Page 37 - Chief Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chief Development. Real-time updates on events, politics, business and more.
March 3, 2023
Operator: Greetings, and welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in a listen-only mode.
March 3, 2023
WILMINGTON, DE / ACCESSWIRE / March 3, 2023 / The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions
March 2, 2023
The University of New Orleans Athletics' online ticketing platform provider, AudienceView, is currently down due to technical difficulties.
March 2, 2023
/PRNewswire/ -- Pet Supplies Plus ("PSP" or the "Company"), the largest independent pet retailer in North America with over 660 stores in 41 states, and Wag N...
March 1, 2023
Expo City Dubai is gearing up for its next phase on the journey to become a sustainable, people-centric city with the launch of its residential projects, said a top official. It will boast clean, green integrated communities with all lifestyle amenities.
February 28, 2023
The developments, which include apartments, townhouses and villas, offer residents a unique opportunity to be part of the long-term vision of an incredible World Expo and to live in the heart of its proud legacy city.
February 24, 2023
Aruba Airport Authority N.V. hosted the Minister of Tourism, Mr. Dangui Oduber, as he visited the construction site of the airportโs Gateway 2030 project on February 16, 2023
February 23, 2023
/PRNewswire/ -- In anticipation of continued growth, Specialized Dental, the holding company of US Endo Partners (USEP) and Specialized Dental Partners (SDP),...
February 22, 2023
Before joining Rubicon, Schubert held senior executive and advisory roles with multiple public companies.
February 22, 2023
Sustained, elevated expression of alpha-galactosidase A (a-Gal A) activity observed in 13 patients for over two years for the longest treated patient as of cutoff date. Achieved 78% globotriaosylceramide